Marc S. Rudoltz
- Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments 8
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 8
- Rheumatology top 1%
- Eosinophilic Disorders and Syndromes 3
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies 7
- Oncology top 10%
- Cancer-related Molecular Pathways 6
- Lung Cancer Research Studies 3
-
- Salivary Gland Tumors Diagnosis and Treatment 4
-
- DNA Repair Mechanisms 3
- Co-authors
- Brian DrukerFrançois GuilhotTimothy P. HughesJerald P. RadichRichard A. LarsonSusan BranfordAndreas HochhausJohn M. Goldman
- Cited by
- HematologyGeneticsRheumatology
- Journals
- Journal of Clinical Oncology (6 papers)International Journal of Radiation Oncology*Biology*Physics (4 papers)Blood (4 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Marc S. Rudoltz
36 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Hematology 1.4k
- Genetics 1.2k
- Rheumatology 859
- Otorhinolaryngology 208
- Oncology 369
Countries citing papers authored by Marc S. Rudoltz
This map shows the geographic impact of Marc S. Rudoltz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc S. Rudoltz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc S. Rudoltz more than expected).
Fields of papers citing papers by Marc S. Rudoltz
This network shows the impact of papers produced by Marc S. Rudoltz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc S. Rudoltz. The network helps show where Marc S. Rudoltz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Marc S. Rudoltz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 5 | |
| 2 | 2022 | 36 | |
| 3 | 2021 | 10 | |
| 4 | 2020 | 26 | |
| 5 | 2016 | 1 | |
| 6 | 2015 | 1 | |
| 7 | 2011 | 9 | |
| 8 | 2009 | 86 | |
| 9 | Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemiabreakdown → | 2009 | 627 |
| 10 | 2005 | 40 | |
| 11 | 1999 | 34 | |
| 12 | 1999 | 23 | |
| 13 | 1998 | 45 | |
| 14 | 1998 | 14 | |
| 15 | 1998 | 19 | |
| 16 | 1995 | 28 | |
| 17 | 1995 | 59 | |
| 18 | 1993 | 3 | |
| 19 | 1993 | 101 | |
| 20 | 1992 | 1 |
About Marc S. Rudoltz
Marc S. Rudoltz is a scholar working on Otorhinolaryngology, Genetics and Hematology, having authored 36 papers that have together received 2.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (8 papers), Head and Neck Cancer Studies (7 papers), Cancer-related Molecular Pathways (6 papers), Salivary Gland Tumors Diagnosis and Treatment (4 papers), Eosinophilic Disorders and Syndromes (3 papers), DNA Repair Mechanisms (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Hematology (1.4k citations), Genetics (1.2k citations) and Rheumatology (859 citations). Marc S. Rudoltz has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Brian Druker, François Guilhot, Timothy P. Hughes, Jerald P. Radich, Richard A. Larson, Susan Branford, Andreas Hochhaus, John M. Goldman, Manisha Mone and Letizia Foroni. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Blood, Cancer Research and The Laryngoscope.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.